Efficacy and Safety of Baclofen 40 mg/20 mL in an Intrathecal Infusion System
Switching to baclofen 40 mg/20 mL is safe and clinically equivalent to the conventional 10 mg/5 mL formulation when the daily dose is maintained unchanged. Dose reduction appears unsuitable in patients requiring high daily intrathecal baclofen doses.
Authors
- Maurizio Ranieri (ORCID: https://orcid.org/0000-0003-3169-3025)
- Serena Gervasi
- Marisa Megna (ORCID: https://orcid.org/0000-0002-8486-103X)
- Riccardo Marvulli
- Lucrezia dell’Olio (ORCID: https://orcid.org/0009-0005-7576-5758)
- Giuseppa Lagioia
- Serena Caforio Montesardo
Institutions
- University of Bari Aldo Moro (IT)
Publication Details
- Journal
- Life
- Published
- 2026-03-14
- DOI
- https://doi.org/10.3390/life16030473
- Primary Topic
- Botulinum Toxin and Related Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00